The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse Model.
about
The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse Model.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
The BCR-ABL1 Inhibitors Imatin ...... n a Translational Mouse Model.
@en
The BCR-ABL1 Inhibitors Imatin ...... n a Translational Mouse Model.
@nl
type
label
The BCR-ABL1 Inhibitors Imatin ...... n a Translational Mouse Model.
@en
The BCR-ABL1 Inhibitors Imatin ...... n a Translational Mouse Model.
@nl
prefLabel
The BCR-ABL1 Inhibitors Imatin ...... n a Translational Mouse Model.
@en
The BCR-ABL1 Inhibitors Imatin ...... n a Translational Mouse Model.
@nl
P2093
P2860
P356
P1476
The BCR-ABL1 Inhibitors Imatin ...... n a Translational Mouse Model.
@en
P2093
Cornelis Kluft
Elsbet J Pieterman
J Wouter Jukema
Jurjan Aman
Lars Verschuren
Marianne G Pouwer
Martien P M Caspers
Ricardo A Garcia
P2860
P356
10.3389/FCVM.2018.00055
P577
2018-06-12T00:00:00Z